McKesson buys regional drug distributor for $206M

McKesson is buying regional drug distributor D&K Healthcare for $206 million in an effort to build up its operations in the Midwest and South. McKesson -- a giant drug distributor -- is paying a 70 percent premium for the stock.

- read this AP report for more

Suggested Articles

A phase 3 study of NuCana’s lead drug was halted because a monitoring committee deemed it unlikely to succeed.

The filing follows data from Japanese phase 3 trials that assessed the oral HIF-PHI in chronic kidney disease patients.

The Allen Institute found major differences in human and mouse brain cells, which could guide the design of drugs for brain diseases.